Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Ballabeni

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
JIMD Reports|March 6, 2023
Relationship between <i>MAN2B1</i> genotype/subcellular localization subgroups, antidrug antibody detection, and long-term velmanase alfa treatment outcomes in patients with alpha-mannosidosisLine Gutte Borgwardt, Ferdinando Ceravolo, Giulia Zardi, et al.
The Journal of Biological Chemistry|December 5, 2008
Human CDT1 associates with CDC7 and recruits CDC45 to chromatin during S phaseAndrea Ballabeni, Raffaella Zamponi, Greta Caprara, et al.
The Journal of Cell Biology|May 26, 2004
Loss of Geminin induces rereplication in the presence of functional p53Marina Melixetian, Andrea Ballabeni, Laura Masiero, et al.
Orphanet Journal of Rare Diseases|July 23, 2022
Mortality in patients with alpha-mannosidosis: a review of patients' data and the literatureJulia B Hennermann, Eva M Raebel, Francesca Donà, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Cell cycle adaptations of embryonic stem cellsAndrea Ballabeni, In-Hyun Park, Rui Zhao, et al.
Journal of Inherited Metabolic Disease|October 9, 2024
Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosisNathalie Guffon, Line Borgwardt, Anna Tylki-Szymańska, et al.
International Journal of Fertility and Women'S Medicine|August 12, 2004
Developmental outcomes at one and two years of children conceived by intracytoplasmic sperm injectionGiovanni Battista La Sala, Andrea Gallinelli, Piergiuseppina Fagandini, et al.
Journal of Inherited Metabolic Disease|February 28, 2023
Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter studyNathalie Guffon, Vassiliki Konstantopoulou, Julia B Hennermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2014
A nontranscriptional role for Oct4 in the regulation of mitotic entryRui Zhao, Richard W Deibler, Paul H Lerou, et al.
Orphanet Journal of Rare Diseases|May 7, 2025
Evolution of mobility, pain/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient surveyKarolina M Stepien, Sophie Thomas, Julia B Hennermann, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JIMD Reports|March 6, 2023
Relationship between <i>MAN2B1</i> genotype/subcellular localization subgroups, antidrug antibody detection, and long-term velmanase alfa treatment outcomes in patients with alpha-mannosidosisLine Gutte Borgwardt, Ferdinando Ceravolo, Giulia Zardi, et al.
The Journal of Biological Chemistry|December 5, 2008
Human CDT1 associates with CDC7 and recruits CDC45 to chromatin during S phaseAndrea Ballabeni, Raffaella Zamponi, Greta Caprara, et al.
The Journal of Cell Biology|May 26, 2004
Loss of Geminin induces rereplication in the presence of functional p53Marina Melixetian, Andrea Ballabeni, Laura Masiero, et al.
Orphanet Journal of Rare Diseases|July 23, 2022
Mortality in patients with alpha-mannosidosis: a review of patients' data and the literatureJulia B Hennermann, Eva M Raebel, Francesca Donà, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Cell cycle adaptations of embryonic stem cellsAndrea Ballabeni, In-Hyun Park, Rui Zhao, et al.
Journal of Inherited Metabolic Disease|October 9, 2024
Extended long-term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha-mannosidosisNathalie Guffon, Line Borgwardt, Anna Tylki-Szymańska, et al.
International Journal of Fertility and Women'S Medicine|August 12, 2004
Developmental outcomes at one and two years of children conceived by intracytoplasmic sperm injectionGiovanni Battista La Sala, Andrea Gallinelli, Piergiuseppina Fagandini, et al.
Journal of Inherited Metabolic Disease|February 28, 2023
Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter studyNathalie Guffon, Vassiliki Konstantopoulou, Julia B Hennermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2014
A nontranscriptional role for Oct4 in the regulation of mitotic entryRui Zhao, Richard W Deibler, Paul H Lerou, et al.
Orphanet Journal of Rare Diseases|May 7, 2025
Evolution of mobility, pain/discomfort, self-care, and mental health in patients with alpha-mannosidosis: an international caregiver and patient surveyKarolina M Stepien, Sophie Thomas, Julia B Hennermann, et al.
Pageof 2